Literature DB >> 24905236

Major depression and suicide attempts in patients with liver disease in the United States.

Yann Le Strat1,2,3,4, Bernard Le Foll4,5,6, Caroline Dubertret1,2,3.   

Abstract

BACKGROUND & AIMS: Depression is common in patients with liver disease. Moreover, alcohol use is intricately linked with both major depression and liver disease, and has also been linked with suicidal behaviours, suggesting that the alcohol use may have an intermediate role in the relationship between liver disease and major depression or suicidal behaviours. This study presents nationally representative data on the prevalence of major depression in patients with liver disease in the United States and its association with suicide attempts.
METHODS: Data were drawn from the 2001-2002 National Epidemiologic Survey on Alcohol and Related Conditions (NESARC). The NESARC is a survey of 43 093 adults aged 18 years and older in the United States. Medically recognized liver diseases were self-reported, and diagnoses of major depression were based on the Alcohol Use Disorder and Associated Disabilities Interview Schedule-DSM-IV version. RESULT: The prevalence of liver disease was estimated at 0.7%. Respondents with a liver disease reported 12-month rates of major depression (17.2%) that were significantly higher than among respondents without liver disease (7.0%; Adjusted OR:2.2; CI: 1.2-4.1). Lifetime rates of suicide attempts among participants with a major depression were also higher in participants with a liver disease (33.2%) than among respondents without liver disease (13.7%; OR: 3.1; CI: 1.3-7.6).
CONCLUSIONS: Liver diseases are associated with major depression and suicide attempts among adults in the community. Adjustment for the amount of alcohol used or sociodemographical factors did not explain the observed association of liver disease with both major depression and suicide attempts.
© 2014 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  depression; epidemiology; liver disease; psychiatry; suicide; survey

Mesh:

Year:  2014        PMID: 24905236     DOI: 10.1111/liv.12612

Source DB:  PubMed          Journal:  Liver Int        ISSN: 1478-3223            Impact factor:   5.828


  10 in total

1.  The clinical implication of psychiatric illnesses in patients with alcoholic liver disease: an analysis of US hospitals.

Authors:  David Uihwan Lee; Harrison Chou; Edwin Wang; Gregory Hongyuan Fan; John Han; Kevin Chang; Jean Kwon; Ki Jung Lee; Jeremy Blanchard; Nathalie Helen Urrunaga
Journal:  Expert Rev Gastroenterol Hepatol       Date:  2022-06-19       Impact factor: 4.095

Review 2.  The National Epidemiologic Survey on Alcohol and Related Conditions (NESARC) Waves 1 and 2: review and summary of findings.

Authors:  Deborah S Hasin; Bridget F Grant
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2015-07-26       Impact factor: 4.328

3.  Impact of depressive symptoms and hepatic encephalopathy on health-related quality of life in cirrhotic hepatitis C patients.

Authors:  Katherine C Barboza; Lilian M Salinas; Farhad Sahebjam; Arun B Jesudian; Ilan L Weisberg; Samuel H Sigal
Journal:  Metab Brain Dis       Date:  2016-03-31       Impact factor: 3.584

4.  Metabolite identification in fecal microbiota transplantation mouse livers and combined proteomics with chronic unpredictive mild stress mouse livers.

Authors:  Bo Li; Kenan Guo; Li Zeng; Benhua Zeng; Ran Huo; Yuanyuan Luo; Haiyang Wang; Meixue Dong; Peng Zheng; Chanjuan Zhou; Jianjun Chen; Yiyun Liu; Zhao Liu; Liang Fang; Hong Wei; Peng Xie
Journal:  Transl Psychiatry       Date:  2018-01-31       Impact factor: 6.222

5.  Rare but heard: using asynchronous virtual focus groups, interviews and roundtable discussions to create a personalised psychological intervention for primary sclerosing cholangitis: a protocol.

Authors:  Veronica Ranieri; Eilis Kennedy; Martine Walmsley; Doug Thorburn; Kathy McKay
Journal:  BMJ Open       Date:  2019-10-02       Impact factor: 2.692

6.  SNI case of the week: Initial concomitant use of gabapentin, clonidine, and prednisone may enhance suicidal ideation: A case report.

Authors:  Ramsis F Ghaly; Ana Plesca; Kenneth D Candido; Nebojsa Nick Knezevic
Journal:  Surg Neurol Int       Date:  2020-03-06

7.  Depressive symptoms and risk of liver-related mortality in individuals with hepatitis B virus infection: a cohort study.

Authors:  In Young Cho; Yoosoo Chang; Eunju Sung; Won Sohn; Jae-Heon Kang; Hocheol Shin; Seungho Ryu
Journal:  Sci Rep       Date:  2020-11-30       Impact factor: 4.379

8.  Melatonin Alleviates Neuroinflammation and Metabolic Disorder in DSS-Induced Depression Rats.

Authors:  Wei-Jie Lv; Cui Liu; Lin-Zeng Yu; Jia-Hao Zhou; Yue Li; Ying Xiong; Ao Guo; Li-Min Chao; Qian Qu; Guang-Wei Wei; Xing-Gang Tang; Yu-Long Yin; Shi-Ning Guo
Journal:  Oxid Med Cell Longev       Date:  2020-07-30       Impact factor: 6.543

9.  Protective Effects of Liu Wei Di Huang Wan on the Liver, Orbitofrontal Cortex Nissl Bodies, and Neurites in MSG+PH-Induced Liver Regeneration Rat Model.

Authors:  Bin-Bin Zhao; Qing-Hua Long; Chao-Yang Wang; Lin-Lin Chen; Guang-Jing Xie; Wen-Ji Bo; Bo Xu; Ze-Fei Li; Han-Min Li; Ping Wang
Journal:  Evid Based Complement Alternat Med       Date:  2018-08-27       Impact factor: 2.629

10.  Preventive Effects of Escitalopram Against Anxiety-Like Depressive Behaviors in Monosodium Glutamate-Teated Rats Subjected to Partial Hepatectomy.

Authors:  Bin-Bin Zhao; Lin-Lin Chen; Qing-Hua Long; Guang-Jing Xie; Bo Xu; Ze-Fei Li; Ping Wang; Hanmin Li
Journal:  Front Psychol       Date:  2019-11-12
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.